Literature DB >> 17971374

Chlamydia trachomatis RNA in the environment: is there potential for false-positive nucleic acid amplification test results?

E Meader1, J Waters, M Sillis.   

Abstract

OBJECTIVES: The ability of molecular methods to detect low levels of nucleic acid has led to the widespread application of techniques based on nucleic acid amplification tests in microbiological diagnosis. This exquisite sensitivity is recognised in the laboratory to require stringent precautions to avoid contamination, but this is not widely appreciated in clinical settings where samples are initially collected, and may be a particular problem in the non-clinical settings used for sampling as part of the National Chlamydia Screening Programme. There is thus the need to characterise the risk of false-positive results caused by environmental contamination in these areas.
METHODS: The extent of environmental contamination of Chlamydia trachomatis (CT) nucleic acid in clinical settings was investigated by swabbing surfaces within the vicinity of specimen collection. Laboratory experiments were designed to monitor the persistence of ribosomal RNA under simulated conditions and to investigate whether contamination of patients' specimens is a risk if environmental surfaces are contaminated. The Gen-Probe APTIMA Combo 2 system was used for CT rRNA detection.
RESULTS: CT rRNA was detected in swabs taken from examination rooms and toilet areas. Tests showed that this could persist for at least 50 days. The potential for clinical samples to become contaminated as a result of the presence of CT rRNA in the immediate environment was demonstrated in this simulated test.
CONCLUSION: This study demonstrated that there is a risk of false-positive nucleic acid amplification test results, when samples are taken in an area that is contaminated with target nucleic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971374     DOI: 10.1136/sti.2007.027862

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  6 in total

1.  High prevalence of rectal gonorrhea and Chlamydia infection in women attending a sexually transmitted disease clinic.

Authors:  Jose A Bazan; Patricia Carr Reese; Allahna Esber; Samantha Lahey; Melissa Ervin; John A Davis; Karen Fields; Abigail Norris Turner
Journal:  J Womens Health (Larchmt)       Date:  2015-02-18       Impact factor: 2.681

2.  Analysis of laboratory testing results collected in an enhanced chlamydia surveillance system in Australia, 2008-2010.

Authors:  Wayne Dimech; Megan S C Lim; Caroline Van Gemert; Rebecca Guy; Douglas Boyle; Basil Donovan; Margaret Hellard
Journal:  BMC Infect Dis       Date:  2014-06-12       Impact factor: 3.090

3.  Multisite Direct Determination of the Potential for Environmental Contamination of Urine Samples Used for Diagnosis of Sexually Transmitted Infections.

Authors:  Patiyan Andersson; Steven Y C Tong; Rachael A Lilliebridge; Nicole C Brenner; Louise M Martin; Emma Spencer; Jennifer Delima; Gurmeet Singh; Frances McCann; Carolyn Hudson; Tracy Johns; Philip M Giffard
Journal:  J Pediatric Infect Dis Soc       Date:  2013-12-19       Impact factor: 3.164

4.  Primary health clinic toilet/bathroom surface swab sampling can indicate community profile of sexually transmitted infections.

Authors:  Philip M Giffard; Jiunn-Yih Su; Patiyan Andersson; Deborah C Holt
Journal:  PeerJ       Date:  2017-06-22       Impact factor: 2.984

5.  Contaminated fingers: a potential cause of Chlamydia trachomatis-positive urine specimens.

Authors:  Philip M Giffard; Rachael A Lilliebridge; Judith Wilson; Gerald Murray; Samuel Phillips; Sepehr N Tabrizi; Suzanne M Garland; Louise Martin; Gurmeet Singh; Steven Y C Tong; Deborah C Holt; Patiyan Andersson
Journal:  Sex Transm Infect       Date:  2017-06-09       Impact factor: 3.519

6.  Comparison between Abbott m2000 RealTime and Alinity m STI systems for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium.

Authors:  Björn Herrmann; Karin Malm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-15       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.